89bio, Inc. - stock earnings
ETNB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -40.2 million USD | ? USD |
| 2023Q3 | -34.7 million USD | ? USD |
| 2023Q2 | -38.4 million USD | ? USD |
| 2023Q1 | -84.1 million USD | ? USD |
| 2022Q4 | -24.6 million USD | ? USD |
| 2022Q3 | -26.8 million USD | ? USD |
| 2022Q2 | -25.4 million USD | ? USD |
| 2022Q1 | -25.6 million USD | ? USD |
| 2021Q4 | -26.3 million USD | ? USD |
| 2021Q3 | -28.3 million USD | ? USD |
| 2021Q2 | -20.7 million USD | ? USD |
| 2021Q1 | -14.8 million USD | ? USD |
| 2020Q4 | -12.6 million USD | ? USD |
| 2020Q3 | -14.6 million USD | ? USD |
| 2020Q2 | -11.8 million USD | ? USD |
| 2020Q1 | -10.5 million USD | ? USD |
| 2019Q4 | -19.3 million USD | ? USD |
| 2019Q3 | -18.7 million USD | ? USD |
| 2019Q2 | -15.0 million USD | ? USD |
| 2019Q1 | -4.4 million USD | ? USD |
| 2018Q4 | -4.6 million USD | ? USD |
| 2018Q3 | -4.2 million USD | ? USD |
ETNB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -142.2 million USD | ? USD |
| 2022 | -102.0 million USD | ? USD |
| 2021 | -90.1 million USD | ? USD |
| 2020 | -49.5 million USD | ? USD |
| 2019 | -57.4 million USD | ? USD |
| 2018 | -16.2 million USD | ? USD |
ETNB
Price: $8.26
52 week price:
Earnings Per Share: -2.00 USD
P/E Ratio: -5.21
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.6 million
Market Capitalization: 1.0 billion